Fight Bladder Cancer’s Post

Navigating a #lungcancer journey can be challenging. Getting trusted, accurate information shouldn't be. Head to LCRF.org/resources to access medically vetted information to help chart your path. #informationispower

Navigating a #lungcancer journey can be challenging. Getting trusted, accurate information shouldn't be. Head to LCRF.org/resources to access medically vetted information to help chart your path. #informationispower

Navigating a #lungcancer journey can be challenging. Getting trusted, accurate information shouldn't be. Head to LCRF.org/resources to access medically vetted information to help chart your path. #informationispower

Navigating a #lungcancer journey can be challenging. Getting trusted, accurate information shouldn't be. Head to LCRF.org/resources to access medically vetted information to help chart your path. #informationispower

Navigating a #lungcancer journey can be challenging. Getting trusted, accurate information shouldn't be. Head to LCRF.org/resources to access medically vetted information to help chart your path. #informationispower

#OvarianCancer is on the rise, with cases set to increase 55% by 2050. Knowing these five facts about #OvarianCancer can save lives. #WorldOvarianCancerDay is May 8. #NoWomanLeftBehind #WOCD2024

🔬 Exciting breakthrough in ovarian cancer detection! Our prospective study at Chengdu Maternal and Child Health Hospital unveils promising results in utilizing blood cell-free DNA (cfDNA) methylation levels for early detection and triage management of ovarian cancer. 📊 Methodology: We meticulously examined 151 patients, evaluating CA125, HE4, ROMA index, and methylation levels of CDO1 and HOXA9. Univariate and multivariate analyses identified high-risk factors, while the efficacy of methylation detection was assessed using AUC. 💡 Key Findings: Patients with ovarian cancer showed elevated levels of age, menopausal status, CA125, HE4, ROMA index, CDO1, and HOXA9 methylation. The combination of CDO1 and HOXA9 methylation testing exhibited the highest AUC of 0.936, with 89.7% sensitivity and 97.5% specificity. Notably, early-stage ovarian cancer detection rates were particularly promising at 85.7%. 🔍 Conclusion: Our study underscores the potential of blood cfDNA methylation detection, offering a simple and non-invasive approach with high sensitivity, especially when combined with CDO1 and HOXA9 methylation testing. This method holds promise in reducing invasive procedures, alleviating patient anxiety, and improving detection compliance, marking a significant stride towards effective ovarian cancer triage. #OvarianCancer #MedicalResearch #EarlyDetection

Have you signed up to receive our newsletter yet? It's a great way to keep you updated on what we have planned, and events that have taken place. Just visit our website and scroll to the bottom of the page to sign up. https://lnkd.in/dy6wSSQ #BreastFriends #BreastCancer #SupportGroup #BreastCancerSupport #CheckYourself

As the end of the year approaches, we're taking stock of what UKLCC and its members have achieved by working together to improve outcomes for those affected by #LungCancer. Read our impact report 📕 https://ow.ly/kNTV50Q5zKS

Their work in clinical trials and multidisciplinary strategies is essential for enhancing survival rates and quality of life for those affected. Let's support and spread awareness about this crucial cause. Subscribe to: https://lnkd.in/eEMW_CyS to learn more. #SarcomaAwareness #BoneCancerAwareness #CancerResearch #SupportCancerResearch #EORTC #FightCancer